Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 97.60
+3.80 (4.05%)
May 6, 2026, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.57 billion as of May 6, 2026. Its market cap has increased by 4.31% in one year.
Market Cap
1.57B
Enterprise Value
1.55B
Revenue
257.50M
Ranking
n/a
PE Ratio
104.84
Stock Price
97.60
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 1.57B, an increase of 16.50%. That is a compound annual growth rate of 3.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 1.57B | -17.20% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 147.95B |
| Getinge AB | 49.99B |
| Sectra AB | 49.17B |
| Camurus AB | 31.73B |
| Saniona AB | 1.93B |
| Cereno Scientific AB | 1.90B |
| Surgical Science Sweden AB | 1.67B |
| Carasent AB | 1.64B |